FDA-European Medicines Agency Leadership To Discuss Pharmacovigilance At DIA Annual Meeting

The U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) will discuss common objectives and challenges in pharmacovigilance and clinical safety at DIA’s Annual Meeting June 15-19 in San Diego.

The June 17 session, FDA-EMA Collaboration in Pharmacovigilance: Common Objectives and Common Challenges, will focus on joint efforts in drug-specific evaluation, drug development, effective implementation of new pharmacovigilance (medicine safety) tools and addressing common challenges.

Help employers find you! Check out all the jobs and post your resume.